{"id":"W2550696258","doi":"10.1093/eurheartj/ehw570","title":"Systolic blood pressure, cardiovascular outcomes and efficacy and safety of sacubitril/valsartan (LCZ696) in patients with chronic heart failure and reduced ejection fraction: results from PARADIGM-HF","year":2016,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":216,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"National Heart, Lung, and Blood Institute; Servier; Alnylam Pharmaceuticals; AstraZeneca; Amgen","keywords":"Medicine; Valsartan; Enalapril; Sacubitril; Heart failure; Sacubitril, Valsartan; Blood pressure; Cardiology; Internal medicine; Ejection fraction; Hazard ratio; Clinical endpoint; ACE inhibitor; Angiotensin-converting enzyme; Clinical trial; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006737851,0.0002252172,0.0007407708,0.000179925,0.0001373302,0.00004403404,0.00003627459,0.00005159883,0.00001872127],"category_scores_gemma":[0.0001065975,0.0001372608,0.00009221031,0.000116041,0.00009195504,0.0002225755,0.00004953493,0.0002352585,0.000006226001],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004719239,"about_ca_system_score_gemma":0.00004762696,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005397341,"about_ca_topic_score_gemma":0.00001390971,"domain_scores_codex":[0.9981335,0.0003909701,0.0004574474,0.0003794225,0.0003827685,0.0002558711],"domain_scores_gemma":[0.9990904,0.000143634,0.0001400509,0.0003298922,0.00006484852,0.0002311888],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002341645,0.0004112879,0.9847922,0.0001110062,0.002471204,0.0001445688,0.0002406742,0.00001437849,0.001595762,0.00001323631,0.002174586,0.005689423],"study_design_scores_gemma":[0.02023229,0.001025489,0.916648,0.0007293061,0.00100394,0.0001808099,0.00002519856,0.000003372332,0.0002649848,0.000004167724,0.05973907,0.0001434248],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9926892,0.003156387,0.00003977595,0.003202977,0.00008545059,0.0006402987,0.00002239423,0.0000280582,0.0001354883],"genre_scores_gemma":[0.9982571,0.0005299891,0.0007563722,0.00005745804,0.0002098135,0.000002855365,0.00000989631,0.00003407788,0.0001424215],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06814428,"threshold_uncertainty_score":0.5597333,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01375539312246582,"score_gpt":0.2399470154632738,"score_spread":0.226191622340808,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}